Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome

E Ficker1, D Thomas, P C Viswanathan

  • 1Rammelkamp Center for Education and Research, Case Western Reserve University, Cleveland, Ohio 44109, USA.

Insights

A novel mutation in the HERG gene (KCNH2) causes hereditary long QT syndrome (hLQTS) due to protein misprocessing, not altered channel function. This discovery highlights the need for personalized treatments for hLQTS patients.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Ion Channel Physiology

Background:

  • Hereditary long QT syndrome (hLQTS) is a genetic disorder causing arrhythmias and sudden death.
  • Mutations in the HERG (KCNH2) gene are a common cause of hLQTS, typically reducing potassium channel function.
  • Understanding mutation mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • Investigate the functional and trafficking properties of a novel HERG COOH-terminal missense mutation, R752W.
  • Determine the molecular basis for hLQTS in a family with this mutation.
  • Classify the mutation to inform potential therapeutic strategies.

Main Methods:

  • Genetic analysis of a family with hLQTS to identify the R752W mutation.
  • Expression of wild-type and mutant HERG cRNA in Xenopus oocytes.
  • Electrophysiological recordings to measure potassium currents.
  • Mammalian cell culture to assess protein trafficking and localization.
  • Computer simulations using the Luo-Rudy model.

Main Results:

  • The HERG R752W mutation segregated with hLQTS in the studied family.
  • Expressed mutant channels showed enhanced currents in oocytes, contrary to expectations.
  • Simulations predicted normal or shortened cardiac action potentials.
  • The mutant protein exhibited intracellular retention, indicating a trafficking defect in mammalian cells.
  • Lower incubation temperatures rescued channel trafficking to the plasma membrane, restoring function.

Conclusions:

  • HERG R752W represents a novel class of trafficking-deficient mutants in hLQTS.
  • This mutation causes hLQTS through impaired protein transport, not altered channel gating.
  • The diverse mechanisms of HERG channel dysfunction necessitate tailored therapeutic approaches for hLQTS.
  • Future treatments must consider the specific class of trafficking defect for optimal efficacy.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...